| Clasificación | Nombre de la clínica | Valoración del paciente | País | Médico principal | experiencia | Técnicas | Mejor para | Por qué está clasificado | Acreditaciones |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.7 / 5 (3) | Seúl, Corea del Sur | — | — | — | — | — | Straumann® Dental Implant System Official Provider | |
| #2 | 4.5 / 5 (23) | Seúl, Corea del Sur | 45,000+ tratamientos | Cirugía de cáncer de páncreas, Análisis extendido de sangre | — | — | International Organization for Standardization, Korean Institute for Healthcare Accreditation | ||
| #3 | 5.0 / 5 (9) | Seúl, Corea del Sur | — | — | Quimioterapia para el cáncer de mama, Biopsia | — | — | Joint Commission International , Korean Institute for Healthcare Accreditation | |
| #4 | 4.8 / 5 (6) | Seúl, Corea del Sur | — | 32,000+ tratamientos | Gastroscopia, Tomografía computarizada de la parte del cuerpo | — | — | Global Healthcare Accreditation Program, World's Best Hospitals 2021 by Newsweek | |
| #5 | 4.5 / 5 (7) | Seúl, Corea del Sur | — | 65,000+ tratamientos | Cirugía de cáncer de páncreas, Diagnóstico complejo del cáncer de páncreas | — | — | International Organization for Standardization, Korean Institute for Healthcare Accreditation | |
| #6 | 4.8 / 5 (5) | Incheon, Corea del Sur | — | — | Análisis extendido de sangre, TC (tomografía computarizada) | — | — | World's Best Hospitals 2021 by Newsweek | |
| #7 | 4.5 / 5 (43) | Seúl, Corea del Sur | — | — | CyberKnife, Gamma Knife | — | — | Joint Commission International , Korean Institute for Healthcare Accreditation | |
| #8 | 3.5 / 5 (4) | Seúl, Corea del Sur | — | — | — | — | — | Joint Commission International , Korean Institute for Healthcare Accreditation | |
| #9 | 5.0 / 5 (2) | Seúl, Corea del Sur | — | — | TC (tomografía computarizada), Análisis extendido de sangre | — | — | World's Best Hospitals 2021 by Newsweek | |
| #10 | 5.0 / 5 (1) | Seúl, Corea del Sur | — | — | Gamma Knife, TEP/TC | — | — | World's Best Hospitals 2021 by Newsweek, World's Best Smart Hospitals 2021 by Newsweek |